Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

5.0K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.0K
Asthma-I: Introduction01:29

Asthma-I: Introduction

3.5K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.5K
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

3.4K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
3.4K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

3.2K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.2K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

1.4K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.4K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

4.4K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Twelve-Month Real-World Outcomes of Tezepelumab in Severe Asthma: Clinical Remission, Biomarker Changes, and Trigger Burden-A SANI Multicenter Cohort.

Journal of personalized medicine·2026
Same author

Use of an Anti-Thymic Stromal Lymphopoietin Agent in Patients With Asthma and Clinically Significant Bronchiectasis: A Case Series.

Chest·2026
Same author

Impact of Biologics Administered for Severe Asthma on T2-comorbidities: A Narrative Review.

Archivos de bronconeumologia·2026
Same author

Blended reactions and angioedema are common in patients with cross-reactive nonsteroidal anti-inflammatory drug hypersensitivity.

Asia Pacific allergy·2026
Same author

Functional response, in T2 severe asthmatic patients, treated with mepolizumab for 2 years.

The Journal of asthma : official journal of the Association for the Care of Asthma·2026
Same author

Silent invaders: the role of MPs on epithelium inflammation and damage in airway diseases.

Frontiers in allergy·2026

Related Experiment Video

Updated: Feb 8, 2026

Trichuris muris Infection: A Model of Type 2 Immunity and Inflammation in the Gut
10:05

Trichuris muris Infection: A Model of Type 2 Immunity and Inflammation in the Gut

Published on: May 24, 2011

16.9K

Type 2 immunity in asthma.

Marco Caminati1, Duy Le Pham2, Diego Bagnasco3

  • 11Asthma Center and Allergy Unit, Verona University Hospital, Piazzale Scuro10, 37134 Verona, Italy.

The World Allergy Organization Journal
|July 11, 2018
PubMed
Summary
This summary is machine-generated.

Type 2-immunity, involving Th2 cells and IgE, typically responds to allergens. Environmental factors and epithelial dysfunction also drive this inflammation, crucial for understanding severe asthma.

Keywords:
Adaptive immunityAllergic sensitizationAsthmaBiologicalsEpithelial dysfunctionInnate immunitySevere asthmaType 2 inflammation

More Related Videos

Acupuncture in a Rat Model of Asthma
07:14

Acupuncture in a Rat Model of Asthma

Published on: August 25, 2020

6.6K
Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

32.5K

Related Experiment Videos

Last Updated: Feb 8, 2026

Trichuris muris Infection: A Model of Type 2 Immunity and Inflammation in the Gut
10:05

Trichuris muris Infection: A Model of Type 2 Immunity and Inflammation in the Gut

Published on: May 24, 2011

16.9K
Acupuncture in a Rat Model of Asthma
07:14

Acupuncture in a Rat Model of Asthma

Published on: August 25, 2020

6.6K
Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

32.5K

Area of Science:

  • Immunology
  • Allergy and Asthma Research

Background:

  • Type 2-immunity, characterized by Th2 cells and immunoglobulin E (IgE), is the primary adaptive response to allergens in atopic individuals.
  • Recent findings indicate that allergens can elicit Th2 responses independently of IgE, and environmental stimuli like viruses and pollutants can trigger similar inflammation, extending beyond atopy.
  • Epithelial dysfunction and innate immunity dysregulation are increasingly recognized as key contributors to asthma pathogenesis, particularly severe asthma.

Purpose of the Study:

  • To review the role of innate and adaptive type 2-immunity dysregulation in asthma pathogenesis, focusing on severe asthma.
  • To update on the specific allergens associated with severe asthma.
  • To discuss current and emerging targeted treatments for severe asthma in the context of type 2-immunity.

Main Methods:

  • This is a review article, synthesizing existing scientific literature.
  • The review focuses on analyzing data related to type 2-immunity, epithelial dysfunction, innate immunity, and environmental factors in asthma.
  • Evidence regarding specific allergens and targeted therapies for severe asthma is evaluated.

Main Results:

  • Allergens, environmental stimuli, epithelial dysfunction, and innate immunity all contribute to type 2-inflammation in asthma.
  • The complex interplay between airway epithelium, innate, and adaptive immunity is a critical determinant of type 2-inflammation, even in non-allergic contexts.
  • Dysregulation of type 2-immunity is central to the pathogenesis of severe asthma.

Conclusions:

  • Understanding the multifaceted triggers of type 2-inflammation, including allergens and non-allergic factors, is essential for managing asthma.
  • Targeted therapies aimed at modulating type 2-immunity pathways show promise for treating severe asthma.
  • Further research into the intricate mechanisms of airway inflammation is crucial for developing effective asthma treatments.